letrozole has been researched along with tomoxiprole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adamo, B; Carey, LA; Chic, N; Conte, B; Conte, P; Cortes, J; Dieci, MV; Fernandez-Martinez, A; Galvan, P; Gavila, J; Griguolo, G; Guarnieri, V; Llombart, A; Muñoz, M; Oliveira, M; Paré, L; Pascual, T; Pernas, S; Perou, CM; Prat, A; Tanioka, M; Vidal, M; Villagrasa, P | 1 |
1 other study(ies) available for letrozole and tomoxiprole
Article | Year |
---|---|
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Imidazoles; Letrozole; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Prognosis; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2021 |